Nordson Corporation, a $2.2b developer of dispensing and fluid management systems for adhesives, industrial coatings, sealants, paints, polymers, fluids and biomaterials, has acquired Fluortek Inc., a maker of precision plastic extrusion products. Fluortek’s offerings include polytetrafluoroethylene, heatshrink, micro-bore, fluoropolymer, thermoplastic, radiopaque and splittable tubing, multi-lumen and profile extrusions, and etched liners for use in central venous, balloon and urinary catheters, …
Conventus Orthopaedics, Inc. Acquires Flower Orthopedics
Conventus Orthopaedics, developer of a self-expanding nitinol cage technology for repairing fractured wrists, elbows, and shoulders and portfolio company of healthcare investment firm Deerfield Management, has acquired Flower Orthopedics, a maker of disposable, sterile-packed, implant and instrument kits. Flower complements Conventus’ orthopedic fracture fixation system with an alternative to reusable implant trays that carry greater bioburden risk and provides entry …
The Walden Group Releases Interim Healthcare Industry Report
The Walden Group is pleased to provide access to an Interim Healthcare Industry Report providing a window into how the healthcare industry is taking steps to resume some semblance of normality. It discusses how medical practices and hospitals are carefully opening up, compliant with Covid-19 safety guidelines. It unpacks the effect of the pandemic on various clinical areas: General Surgery, …
Select M&A Deals and Terminations in the Age of Coronavirus
Select M&A Deals and Terminations in the Age of Coronavirus (Terms not announced unless specified) Beaver-Visitec Acquires Ophthalmic Viscoelastic Device Assets from Croma-Pharma (Austria) Smiths Medical Acquires Access Scientific (US) Zhuhai Baolian Asset Management Plans to Acquire Shanghai Kehua Bio-Engineering (China) — Deal price — $246.9m OncBioMune Pharma to Acquire Avant Diagnostics …
The Walden Group Releases 2020 Q1 Strategic Healthcare M&A Report
The Walden Group, an M&A advisory firm focused on the healthcare industry, has published its complimentary 2020 Q1 Strategic Healthcare M&A Report, available for download on its website, www.waldenmed.com. The report includes analysis of more than 60 M&A transactions announced of closed in Q1, among several other key developments impacting the healthcare industry including: The effect of the …
Big Pharma Invest Deeper into Cancer Treatment
In early December 2019, two of the biggest pharmaceutical companies announced multibillion-dollar deals aiming at bolstering their oncology pipeline. Merck & Co. Inc. is paying $2.5b to acquire ArQule, Inc, whose lead investigational candidate is an oral Bruton’s tyrosine kinase (BTK) inhibitor currently in a Phase II dose-expansion study for the treatment of B-cell malignancies. The transaction enhances Merck’s offerings of therapies that treat blood-related cancers. Sanofi announced it is acquiring Synthorx, …
Orthopedic and Spine Sector Consolidations Tighten the Market
Stryker recently announced purchase of Wright Medical for $4b purchase (4.5x revenue and 38.5x EBITDA) is yet another example of the consolidation within the orthopedic and spine sectors. As reimbursement levels become tighter and margins are challenged, economies of scale become paramount. Wright Medical is a recognized leader in upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) …
Novartis is paying $9.7b to acquire The Medicines Company for a Potentially Blockbuster Cholesterol-Lowering Therapy
The Medicines Company is developing “inclisiran”, a potentially transformational medicine that reimagines the treatment of atherosclerotic heart disease and familial hypercholesterolemia. With tens of millions of patients at higher risk of cardiovascular events from high LDL-C, inclisiran could contribute significantly to improved patient outcomes and help healthcare systems address the leading global cause of death. The Medicines Company plans shortly …
The Restart of Medicare Orthotics & Prosthetics Competitive Bidding Program Adds Margin Pressure on O&P Players
After a pause, The Centers for Medicare & Medicaid Services (CMS) announced plans to reinstate the Competitive Bidding Program for Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies. “Round 2021” competition will cover a total of 130 competitive bidding areas and add new product categories: off-the-shelf (OTS) back braces, OTS knee braces, and non-invasive ventilators. The new rule will put margin …
The Coming of Age of Gene Therapy
In vivo gene therapy, the process of delivering genetic material into the body to cure disease, is a challenging area but has the potential to cure millions suffering from genetic conditions such as cystic fibrosis or muscular dystrophy. With a $40b plus market, gene therapy has the potential to be non-pathogenic to humans and prevent DNA damage and unpredictable consequences. …